Indore Hosts International Conference On AI-Driven Drug Development
Indore Institute of Pharmacy launches 2-day conference on AI in pharma. Experts discuss AI's role.

The Indore Institute of Pharmacy, a part of the IIST Group of Institutes, has inaugurated a two-day International Conference on AI-Enabled Global Drug Development Ecosystem.
The conference, held in collaboration with Biovance Solutions, UK, aims to bring together experts from various fields to discuss the transformative role of Artificial Intelligence in pharmaceutical sciences.
The inaugural ceremony was attended by prominent figures, including Dr Montu K Patel, president of the Pharmacy Council of India, and Dr Deependra Singh, chairman of the Education Regulations Committee.
In his address, Dr Patel highlighted the growing importance of AI and digital transformation in strengthening pharmacy education and professional practice. He also discussed the Pharmacy Council of India's digital initiatives, which aim to improve transparency, accountability, and quality in pharmacy education.
Arun S Bhatnagar, group advisor of Sparsh and IIST Group of Institutes, spoke about the benefits of AI in clinical research, regulatory science, drug discovery, and patient safety.
According to Dr Nimita Manocha, principal of the Indore Institute of Pharmacy, the conference is one of the first comprehensive initiatives in Madhya Pradesh to focus on AI across the pharmaceutical product lifecycle.
The conference provides a platform for academicians, regulatory leaders, industry experts, and healthcare professionals to share their knowledge and experiences on the applications of AI in pharmaceutical sciences.
The use of AI in drug development has the potential to revolutionize the pharmaceutical industry, enabling faster and more efficient discovery of new drugs, improving clinical trials, and enhancing patient safety.
The conference will feature presentations, panel discussions, and workshops, providing attendees with a comprehensive understanding of the current state of AI in pharmaceutical sciences and its future potential.
The event is expected to contribute to the growth of the pharmaceutical industry in Madhya Pradesh, promoting innovation and collaboration among stakeholders.
In conclusion, the International Conference on AI-Enabled Global Drug Development Ecosystem is a significant step towards promoting the use of AI in pharmaceutical sciences, and its outcomes are expected to have a positive impact on the industry as a whole.
Frequently asked questions
What is the purpose of the International Conference on AI-Enabled Global Drug Development Ecosystem?
The conference aims to discuss the transformative role of Artificial Intelligence in pharmaceutical sciences.
Who attended the inaugural ceremony of the conference?
The ceremony was attended by Dr Montu K Patel, president of the Pharmacy Council of India, and Dr Deependra Singh, chairman of the Education Regulations Committee.